Nichi-Iko Pharmaceutical Co (Nichi-Iko Pharmaceutical Co) EV-to-EBIT : -1.10 (As of May. 04, 2024)

Nichi-Iko Pharmaceutical Co EV-to-EBIT Chart

Nichi-Iko Pharmaceutical Co Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
EV-to-EBIT		Get a 7-Day Free Trial					19.00	18.30	19.88	97.03	-1.89

Nichi-Iko Pharmaceutical Co Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EV-to-EBIT	Get a 7-Day Free Trial															-15.43	-1.89	-1.78	-1.49	-1.23

Competitive Comparison of Nichi-Iko Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Nichi-Iko Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nichi-Iko Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nichi-Iko Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nichi-Iko Pharmaceutical Co's EV-to-EBIT falls into.

Nichi-Iko Pharmaceutical Co EV-to-EBIT Calculation

Nichi-Iko Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Nichi-Iko Pharmaceutical Co's current Enterprise Value is $1,385 Mil.
Nichi-Iko Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nichi-Iko Pharmaceutical Co  (OTCPK:NHKFF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nichi-Iko Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Nichi-Iko Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2022 was $4,561,078,589 Mil.
Nichi-Iko Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nichi-Iko Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nichi-Iko Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nichi-Iko Pharmaceutical Co (Nichi-Iko Pharmaceutical Co) Business Description